logo
Search orAI Icon𝛼SK
ENTITY
Dr. Reddy's Laboratories

Dr. Reddy's Laboratories (DRRD IN)

210
Analysis
Health Care • India
Dr. Reddy's Laboratories Limited provides a complete range of pharmaceutical services. The Company manufactures bulk drugs and formulations including verapamil and cephalexin. The Company also manufactures and exports molecules such as norfloxacin, ciprofloxacin, and varieties of semi-synthetic penicillin. The Company markets its products in India and around the world.
more
bullish•MSCI Emerging Markets Index
•29 Jan 2020 07:51

EM Pullback Opportunity

Supporting our global bull market thesis, uptrends remain intact for the major global indexes (MSCI ACWI, ACWI ex-US, EAFE, and EM). At this point,...

Logo
Vermilion Research
544 Views
Share
bearish•Thematic (Sector/Industry)
•18 Jun 2019 14:39

Shikha Sharma Rewarded with Prominent Directorships for Mismanagement at Axis Bank

On June 14, 2019, Tech Mahindra (TECHM IN)  joined the ranks of Tata Global Beverages, Ambuja Cements (ACEM IN)  and Dr. Reddy'S Laboratories (DRRD...

Logo
Hemindra Hazari
703 Views
Share
bearish•Sun Pharmaceutical Industries
•08 Mar 2019 11:33

India Generic Drugs: "Antitrust Unredacted"

New information in the government's investigation into antitrust violations by generic drug companies continues to surface. An unredacted version...

Logo
Share
bearish•Cross Asset Strategy
•01 Apr 2025 09:51

Asian Alpha Hedge Fund (AAHF): INTRODUCTION

Asian Alpha Hedge Fund (AAHF) returned 32% in the first quarter of 2025.  The fund outperformed the MSCI All Country Asia Pacific index by 28%. ...

Logo
David Mudd
140 Views
Share
bearish•Aurobindo Pharma
•01 Jan 2019 22:29

India Generic Drugs: Antitrust Suit Could Cost Billions

This Insight builds on our previous Insight, India Generic Drugs: US Antitrust Inquiry Widens by discussing estimated potential liabilities and...

Logo
Share

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.59.7

x